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ABSTRACT
Objectives: This study aimed to evaluate the UBI MAGIWELTM ζ-GLOBIN ELISA Kit
for the presumptive diagnosis of αo-thalassaemia.  The ELISA results obtained were
confirmed by molecular characterisation of αo-thalassaemia using a Duplex-PCR.  Methods:
Routine peripheral blood counts and red cell indices were determined in 94 blood samples
sent for Hb analysis.  Hb subtypes were quantified by high performance liquid
chromatography (HPLC) and Hb electrophoresis conducted on agarose gel at pH 8.5.
Zeta-globin chain levels were determined using the UBI MAGIWELTM ζ-GLOBIN ELISA
Kit.  Molecular analysis was performed using a duplex-PCR which simultaneously amplifies
a normal 136 bp sequence between the ψα−α2-globin genes and a 730 bp Southeast Asian
deletion-specific sequence (–SEA) between the ψα2−θ1-globin genes.  Results: Using the
ELISA assay kit, 20 blood samples were presumptively identified as α-thalassaemia carriers
from elevated ζ-globin chains (OD>0.3) while the remaining 74 blood samples showed
OD<0.3.  Molecular characterisation confirmed amplification of the 136 bp normal fragment
in all the blood samples. Seventeen of the 20 DNA samples from the α-thalassaemia
carriers amplified the SEA-deletion specific fragment.  The remaining three DNA samples
did not amplify the SEA-deletion specific fragment but amplified the normal α-globin gene
sequence, indicating the presence of amplifiable DNA in these samples.  Further molecular
characterisation of the α-3.7 and -α4.2 deletions and Hb Constant Spring (CS) mutation
showed the absence of these defects in these 3 DNA samples. Conclusion:  This preliminary
investigation showed the sensitivity and specificity of the UBI MAGIWEL ζ-globin
ELISA kit as 100 % and 96.1 % respectively in the detection of α-thalassaemia-1 carriers
(–SEA).
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INTRODUCTION
Thalassaemia is a genetic blood disorder of haemoglobin synthesis and is the most common
inherited haematological disorder in Malaysia.  Thalassaemia is a public health problem in
Malaysia as the incidence of α-thalassaemia carriers among the Malays and Chinese is
approximately 3-4 %.[1]  However, the majority of these α-thalassaemia carriers are unaware
of  their  thalassaemia  status  as α-thalassaemia-1 or  α0 (–/aa) and  α-thalassaemia-2 or α+
(-α/αα) are asymptomatic and difficult to detect haematologically.
Alpha-thalassaemia is caused by deletions or mutations within the α-globin gene
complex and this leads to a decrease or an absence of α-globin chain production. Alpha-
thalassaemia can result from a deletion of either one (α+-thalassaemia) or both (α0-
thalassaemia) α-globin genes.[2]  The most severe form of α-thalassaemia is Hb Bart’s
hydrops foetalis, a condition that is not compatible with life.  Hb Bart’s hydrops foetalis is
common in Southeast Asia [3] and is responsible for 60-90 % of Bart’s hydrops foetalis cases
in this region.[4]  The estimated frequency of α-thalassaemia carriers in Southeast Asia is
approximately 3-5 % [5] and the Southeast Asian deletion (–SEA) is the most common type of
deletion involved.[6]  The –SEA deletion of 17.5 kb along the α-globin gene involves the
deletion of the ψα2-, ψα1-, α2-, α1-and θ1-genes leaving only the ζ-genes intact (Fig.1).[7, 8]
Figure 1.  Southeast Asian deletion in the α-globin gene cluster
Note: Genes are represented as solid boxes, pseudogenes as dotted boxes and hypervariable regions
as zigzag lines. The α-globin gene cluster on chromosome 16 is arranged in order telomere - ζ2,
ψζ1, ψα2, ψα1, α2, α1, and θ1 – centromere. The Southeast Asian defect (–SEA) of 17.5 kb
deletes the ψα2, ψα1, α2, α1, and θ1 – globin genes and spares the ζ2, ψζ1 – globin genes.
There is an urgent need to identify carriers of αo-thalassaemia in couples with the SEA-
deletion as they are at risk of producing a gestation with Hb Bart’s hydrops foetalis.
Molecular characterisation and prenatal diagnosis for α-thalassaemia in Malaysia are
currently carried out using a Duplex-PCR.[9]  The duplex-PCR simultaneously amplifies both
the normal sequence between the ψα−α2-globin genes and the SEA-specific deletion in a
single PCR reaction, and thus offers a rapid and specific prenatal diagnosis method for α-
thalassaemia in the Malaysian population.
Adult carriers of αo-thalassaemia with the Southeast Asian deletion (–SEA) have been
reported to possess increased levels (0.01-1%) of embryonic ζ-globin chains in their
erythrocytes.[10,11] The elevated embryonic ζ-globin chains can be detected using
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fluorescence microscopy after immunocytological staining of erythrocytes with anti-human
ζ-globin chain antibodies.[12, 13]  A simpler ζ-globin chain immunosorbent assay (ELISA)
was subsequently developed to detect αo-thalassaemia carriers with the –SEA deletion [14, 15]
and sensitivity of the ζ-globin ELISA assay was reported at 89.3% and specificity at 100%
in a study carried out using peripheral blood.[16]  The ζ-globin ELISA assay offers a simple
and cost-effective diagnostic method for the identification of carriers of (–SEA) deletional αo-
thalassaemia.  In addition, this method can be used in diagnostic laboratories where
equipment and trained staff for molecular diagnosis are not available.  The UBI MAGIWEL
TM Zeta Globin (ZAM) Qualitative Test kit (United Biotech, Mountain View, California, USA)
detects αo-thalassaemia carriers with the (–SEA) deletion and α-thalassaemia-1 carriers from
other α-thalassaemia mutations that spare the embryonic ζ-globin genes and causes traces
of ζ-peptides to persist throughout life.
This project is a preliminary study to evaluate the UBI MAGIWEL TM ζ-globin ELISA kit
for the presumptive diagnosis of  αo-thalassaemia carriers with the (–SEA) deletion.  The
results obtained from the ELISA assay were compared with molecular studies using the
Duplex-PCR to confirm the SEA deletion in αo-thalassaemia carriers.
METHODS
Patient Samples
Three laboratories in the Klang Valley entered 94 (30, 30, 34 per site respectively) blood
samples. Entrance criteria were Hb analysis testing ordered.  The EDTA anticoagulated
whole blood samples were used for automated blood counts, to quantify Hb subtypes by
high performance liquid chromatography (HPLC)  for UBI MAGIWEL TM ζ-globin ELISA kit
analysis and DNA studies.  Routine peripheral blood counts and red cell indices were
determined according to standard laboratory procedures.  Hb analysis was performed on all
blood samples with a MCV <80 fl and MCH <27 pg.  Hb subtypes were quantified by HPLC
using the Variant Hb Analyser (Bio-Rad Laboratories, Hercules, California, USA).  Automated
Hb electrophoresis was conducted on agarose gel at pH 8.5 (Sebia Hydrasys).
UBI MAGIWEL TM ζ-globin ELISA Kit
The UBI MAGIWELTM Zeta Globullin (ZAM) Qualitative Test (United Biotech, Mountain
View, California, USA) is a solid phase enzyme-linked immunosorbent assay (ELISA) that
provides screening for elevated ζ-globin levels in whole blood.  The ELISA was performed
following  manufacturer’s instructions.  Patient’s blood samples (100 µ l) were mixed with
200 sample diluent (200 µ l). 100 µ l of the treated blood sample were dispensed into microplate
wells coated with immobilised antibodies. After incubation at 37oC for 60 minutes, the wells
were washed five times with washing buffer.  Enzyme conjugate was then added and the
wells incubated for another 30 minutes at 37oC before another 5 washes with washing
buffer.  Two solutions (A and B) were mixed and then added to the wells for 15 minutes at
room temperature.  The reaction was stopped with the addition of 50 ml of 1N H2SO4.  Optical
density was read at Absorbance 450 using a microplate reader. A positive colour (yellow)
reaction (OD>0.3) indicates the presence of ζ-globin chain peptides in the blood sample. A
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sample is negative when the OD reading is less than 0.2. Positive (blood from α-thalassaemia-
1 patients with the (–SEA) deletion) and negative (blood from normal individuals) control
blood and blank wells were included in every ELISA assay.
DNA Extraction
DNA was extracted using proteinase K and sodium dodecyl sulphate.  Extracted DNA was
purified by phenol-chloroform and precipitated with ethanol.  Precipitated DNA was washed
in alcohol, air-dried and then solubilised in double distilled water.  DNA concentration and
purity were measured spectrophotometrically.
Duplex-PCR
The duplex-PCR was performed using primers SEA1: 5’-CTCTGTGTTCTCAGTATTGGA
GG-3’and SEA2: 5’-ATATATGGGTCTGGAAGTGTATC-3’ to amplify the 730 bp SEA deletion-
specific sequence.  Primers α1: 5’-TACTGTAGATACCCGTGTACAA-3’ and α2: 5’-
ATCATGATGGAAACATAGTAAT-3’[17]  were used to amplify the 136 bp normal sequence
between the ψα−α2-globin genes.  The PCR cycling conditions were initial denaturation at
95°C for 5 minutes followed by 30 cycles of denaturation at 93°C for 1 minute, annealing at
50°C for 1 minute, synthesis at 72°C for 3 minutes and a final extension at 72°C for 6 minutes.
DNA from a known heterozygote for α-thalassaemia (–SEA/αα), a homozygous αo-
thalassaemia (–SEA/–SEA) and a normal individual (αα/αα) were amplified concurrently in
every PCR to act as positive and negative controls.
Gel Electrophoresis of PCR Products
Amplified PCR products were resolved by electrophoresis on 1.5% agarose gels.
Electrophoresis was carried out at 90 V for 45 minutes.  DNA bands were observed using
ultraviolet light irradiation after ethidium bromide staining and were recorded using a gel
documentation system.
RESULTS
Out of the 94 blood samples sent for Hb analysis, 20 were presumptively identified as αo-
thalassaemia carriers by peripheral blood counts, red cell indices, HPLC analysis and Hb
electrophoresis.   The 20 samples consisted of 14 Chinese and 6 Malay patients.  Using the
UBI MAGIWEL TM ζ-globin ELISA kit, all 20 samples showed elevated ζ-globin chains
(OD>0.3).  The OD reading of the remaining blood samples were <0.3.
Using the duplex PCR, the 136 bp normal ψα−α2-globin gene sequence was confirmed
in all blood samples.  The SEA-deletion specific sequence was not amplified from DNA in
those with an OD reading <0.3.  Seventeen out of the 20 DNA samples from αo-thalassaemia
carriers with elevated ζ-globin chains amplified the SEA-deletion specific sequence.  Three
DNA samples did not amplify the SEA-deletion but amplified the normal 136 bp ψα−α2-
globin gene sequence, indicating the presence of amplifiable DNA in these samples .
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Table 1.   Molecular characterisation of DNA samples
Sample Ethnic A450 136 bp ψα−α2- —SEA α3.7 -α4.2 HbCS
number group globin gene
sequence
1219 Chinese 1.648 Positive Negative Negative Negative Negative
1208 Malay 0.850 Positive Negative Negative Negative Negative
1209 Malay 0.987 Positive Negative Negative Negative Negative
Further molecular characterisation of the α-globin gene showed the absence of the -
α3.7 and -α4.2 deletions in these three samples (Table 1).  In addition, Hb Constant Spring due
to a T-C bp substitution in the termination codon of the α-2 globin gene was also not
present in the three DNA samples.
On comparing the ELISA method with molecular characterisation using Duplex-PCR,
the ELISA method was found to have a sensitivity of 100 % and a specificity of 96.1 %.
DISCUSSION
Molecular characterisation using the duplex-PCR was used to evaluate the ELISA
immunological technique for the detection of αo-thalassaemia carriers with the Southeast
Asian deletion.  The ELISA kit used was the UBI MAGIWEL TM ζ-globin ELISA kit that
detects αo-thalassaemia carriers resulting from the SEA deletion and α-thalassaemia-1 carriers
from other α-thalassaemia mutations that spare the embryonic ζ-globin genes and causes
traces of ζ-peptides to persist throughout life.  Results from this study showed the sensitivity
and specificity of the ELISA kit as 100% and 96.1 % respectively, when using an OD cut-off
value of 0.3 as determined by the manufacturers.  In a study of an ELISA method for ζ-globin
chain detection for αo-thalassaemia carriers with the SEA deletion where a cut-off value of
0.2 was used, the investigators reported the sensitivity and specificity of the ELISA to be
96.4 % and 98.2 % respectively.16
Three of the blood samples with elevated ζ-globin chains detected in this study did not
amplify the SEA deletion-specific sequence (Table 1). In a study of 200 cord bloods for α-
thalassaemia-1 using both ELISA and PCR techniques, one false positive was reported
where the ζ-chains were elevated but PCR confirmed the patient as an α-thalassaemia-2
heterozygote.18 The ELISA method was also reported to be unable to detect the SEA deletion
in some cases of Hb H disease blood samples. 16  The investigators reported that incomplete
lysis of hypochromic microcytic cells together with the low erythrocyte count in Hb H
patients may have produced a smaller quantity of ζ-globin chains  in  the  blood  lysate  and
thus,  produced  the  false-negative  result.
Alpha-thalassaemia with two α-globin gene deletions (–MED) with elevated ζ-globin
chains and positive ELISA results have been reported.11,16 However, molecular
characterisation of  the Mediterranean gene deletion was not carried out in the three DNA
samples that were negative for the SEA deletion in this study. Molecular characterisation of
the single α-gene deletions (-α3.7 and -α4.2) and the non-deletional α-thalassaemia (Hb
Constant Spring) was carried out in the three  DNA  samples.  The  samples were found to
be  negative for these three gene defects.
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Hb Bart’s hydrops foetalis observed in the majority of hydropic pregnancies in the
Malaysian Chinese results from the inheritance of the Southeast Asian deletion from both
parents.  Thus, a simple test for the confirmation of the double α-globin gene deletion in
both chromosomes is sufficient for the antenatal diagnosis of Hb Bart’s hydrops foetalis in
Malaysia.  The duplex-PCR allows the detection of the Southeast Asian deletion and the
normal ψα-α2-globin gene sequence in a single PCR reaction.  It is a rapid, sensitive and
specific method. However, equipment for molecular analysis and trained staff is required.
The UBI MAGIWEL TM ζ-globin ELISA kit is a rapid assay and does not require sophisticated
equipment or highly trained staff.  This preliminary investigation showed sensitivity and
specificity of the UBI MAGIWEL TM ζ-globin ELISA kit as 100 % and 96.1 % respectively.
The sample numbers involved in this study are small and a larger study is needed to
document the specificity of the ELISA method in the detection of the SEA deletion in αo-
thalassemia carriers.
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